EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma

Abstract Background Glioma is the most prevalent primary tumor of the central nervous system. Glioblastoma multiforme (GBM) is the most malignant form of glioma with an extremely poor prognosis. A novel, regulated cell death form of copper-induced cell death called “cuproptosis” provides a new prosp...

Full description

Bibliographic Details
Main Authors: Yujie Zhou, Dongdong Xiao, Xiaobing Jiang, Chuansheng Nie
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Journal of Translational Medicine
Subjects:
Cuproptosis
Bulk RNA-seq analysis
Single cell RNA-seq
Immunohistochemistry
Transwell assays
Flow cytometry cell cycle
Online Access:https://doi.org/10.1186/s12967-023-03883-4

Internet

https://doi.org/10.1186/s12967-023-03883-4

Similar Items